GlassScriptPhysician profile
Stephen A Kinard
NPI 1063498301
$3,604.03
in general payments reported to CMS, 2019-2025
21 companies · $668 in 2025
The $668 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $195 · 2021: $1,299 · 2022: $77.86 · 2023: $807 · 2024: $195 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,670.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southtech Orthopedics | $1,200.00 | 2021 | |
| Amgen INC. | $398.50 | 2024-2025 | Krystexxa |
| Imbed Biosciences INC. | $379.50 | 2023 | |
| Horizon Therapeutics Plc | $314.38 | 2019-2023 | Krystexxa |
| Globus Medical, INC. | $260.88 | 2025 | Senza |
| Integra Lifesciences Corporation | $155.17 | 2023 | Tenoglide |
| Nevro Corp. | $153.59 | 2022-2024 | Senza |
| Zyla Life Sciences, INC. | $122.47 | 2019 | |
| Next Science LLC | $90.18 | 2023 | Surgx, Blastx, Xperience |
| Musculoskeletal Transplant Foundation INC. | $73.12 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $68.62 | 2025 | Purified Cortrophin Gel |
| Polarityte, INC. | $67.34 | 2019-2021 | |
| Smith+Nephew, INC. | $67.14 | 2019-2024 | Grafix Pl, Stravix, Collagenase Santyl |
| Sandoz INC. | $57.98 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $38.41 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $36.80 | 2025 | Inceptiv |
| Kowa Pharmaceuticals America, INC. | $32.21 | 2023 | Seglentis |
| Averitas Pharma INC. | $31.61 | 2023 | Qutenza |
| Convatec INC. | $23.65 | 2023 | |
| Treace Medical Concepts, INC. | $16.93 | 2025 | |
| Sebela Pharmaceuticals INC. | $15.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kinard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.